Similar articles

• Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fit all.

  Tarantini G, Razzolini R, Napodano M, Bilato C, Ramondo A, Iliceto S. Tarantini G, et al. Eur Heart J. 2010 Mar;31(6):676-83. doi: 10.1093/eurheartj/ehp506. Epub 2009 Nov 27. Eur Heart J. 2010. PMID: 19946106 Review.
• Fluoroscopy times and adverse events: a potentially deadly combination.

  Bunting TA, Garcia LA. Bunting TA, et al. J Invasive Cardiol. 2007 May;19(5):215-6. J Invasive Cardiol. 2007. PMID: 17476035 Review. No abstract available.
• Strategies for the invasive treatment of multivessel coronary artery disease.

  Alexopoulos DK. Alexopoulos DK. Hellenic J Cardiol. 2005 Jan-Feb;46(1):16-20. Hellenic J Cardiol. 2005. PMID: 15807390 Review. No abstract available.
• Regression analysis of percutaneous coronary intervention treatment-related time delay.

  MacDonald RD, Welsford M, Arntz HR. MacDonald RD, et al. Am J Cardiol. 2005 Jul 15;96(2):322. doi: 10.1016/j.amjcard.2005.02.003. Am J Cardiol. 2005. PMID: 16018865 No abstract available.
• Determinants of prognostically relevant intracoronary electrocardiogram ST-segment shift during coronary balloon occlusion.

  de Marchi SF, Streuli S, Haefeli P, Gloekler S, Traupe T, Warncke C, Rimoldi SF, Stortecky S, Steck H, Seiler C. de Marchi SF, et al. Am J Cardiol. 2012 Nov 1;110(9):1234-9. doi: 10.1016/j.amjcard.2012.06.023. Epub 2012 Jul 25. Am J Cardiol. 2012. PMID: 22835408